Oral zoliflodacin, an antibiotic that inhibits microbial biosynthesis, effectively treated most cases of uncomplicated urogenital and rectal gonococcal infections, according to a phase 2 trial in the New England Journal of Medicine.
Men and women who had symptoms or untreated urogenital gonorrhea or who had sex in the preceding 2 weeks with a partner with gonorrhea were randomly assigned to receive a single oral dose of zoliflodacin (2 g or 3 g) or to a single 500-mg intramuscular dose of ceftriaxone.
Slomski A. Novel Antibiotic Efficacious in Treating Gonorrhea. JAMA. 2019;321(4):335. doi:10.1001/jama.2018.22029
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: